Email updates

Keep up to date with the latest news and content from Medical Gas Research and BioMed Central.

Open Access Review

The role of Volatile Anesthetics in Cardioprotection: a systematic review

Nicole R Van Allen1, Paul R Krafft1, Arthur S Leitzke1, Richard L Applegate2, Jiping Tang1 and John H Zhang13*

Author Affiliations

1 Department of Physiology, Loma Linda University School of Medicine, Risley Hall, Room 223, Loma Linda, CA 92354, USA

2 Department of Anesthesiology, Loma Linda University School of Medicine, Loma Linda, CA, USA

3 Department of Neurosurgery, Loma Linda University School of Medicine, Loma Linda, CA, USA

For all author emails, please log on.

Medical Gas Research 2012, 2:22  doi:10.1186/2045-9912-2-22

Published: 28 August 2012

Abstract

This review evaluates the mechanism of volatile anesthetics as cardioprotective agents in both clinical and laboratory research and furthermore assesses possible cardiac side effects upon usage. Cardiac as well as non-cardiac surgery may evoke perioperative adverse events including: ischemia, diverse arrhythmias and reperfusion injury. As volatile anesthetics have cardiovascular effects that can lead to hypotension, clinicians may choose to administer alternative anesthetics to patients with coronary artery disease, particularly if the patient has severe preoperative ischemia or cardiovascular instability. Increasing preclinical evidence demonstrated that administration of inhaled anesthetics - before and during surgery - reduces the degree of ischemia and reperfusion injury to the heart. Recently, this preclinical data has been implemented clinically, and beneficial effects have been found in some studies of patients undergoing coronary artery bypass graft surgery. Administration of volatile anesthetic gases was protective for patients undergoing cardiac surgery through manipulation of the potassium ATP (KATP) channel, mitochondrial permeability transition pore (mPTP), reactive oxygen species (ROS) production, as well as through cytoprotective Akt and extracellular-signal kinases (ERK) pathways. However, as not all studies have demonstrated improved outcomes, the risks for undesirable hemodynamic effects must be weighed against the possible benefits of using volatile anesthetics as a means to provide cardiac protection in patients with coronary artery disease who are undergoing surgery.

Keywords:
Cardiac; Cardioprotection; Arrhythmias; Ischemia; Volatile anesthetic gas; Anesthesia